Jilg W - Search Results

1

Low hepatitis B immunogenicity of a hexavalent vaccine widely used in Germany: results of the German Health Survey for Children and Adolescents, 2003-2006.

Jorgensen P, Poethko-Müller C, Hellenbrand W, Jilg W, Thierfelder W, Meyer C, an der Heiden M, Schlaud M, Radun D. Jorgensen P, et al. Among authors: jilg w. Epidemiol Infect. 2010 Nov;138(11):1621-9. doi: 10.1017/S0950268810000543. Epub 2010 Mar 17. Epidemiol Infect. 2010. PMID: 20233496

2

Hepatitis E virus seroprevalence among adults, Germany.

Faber MS, Wenzel JJ, Jilg W, Thamm M, Höhle M, Stark K. Faber MS, et al. Among authors: jilg w. Emerg Infect Dis. 2012 Oct;18(10):1654-7. doi: 10.3201/eid1810.111756. Emerg Infect Dis. 2012. PMID: 23018055 Free PMC article.

3

Prevention of viral hepatitis in the Nordic countries and Germany.

Fitzsimons D, François G, Alpers K, Radun D, Hallauer J, Jilg W, Gerlich W, Rombo L, Blystad H, Nøkleby H, van Damme P. Fitzsimons D, et al. Among authors: jilg w. Scand J Infect Dis. 2005;37(8):549-60. doi: 10.1080/00365540510043284. Scand J Infect Dis. 2005. PMID: 16099768 Review.

4

The economic burden of hepatitis B in Germany.

Harbarth S, Szucs T, Berger K, Jilg W. Harbarth S, et al. Among authors: jilg w. Eur J Epidemiol. 2000 Feb;16(2):173-7. doi: 10.1023/a:1007624415699. Eur J Epidemiol. 2000. PMID: 10845268

5

Autochthonous hepatitis E virus infection in Germany with sequence similarities to other European isolates.

Preiss JC, Plentz A, Engelmann E, Schneider T, Jilg W, Zeitz M, Duchmann R. Preiss JC, et al. Among authors: jilg w. Infection. 2006 Jun;34(3):173-5. doi: 10.1007/s15010-006-4132-x. Infection. 2006. PMID: 16804663

6

Four-year experience with a recombinant hepatitis B vaccine.

Jilg W, Schmidt M, Deinhardt F. Jilg W, et al. Infection. 1989 Mar-Apr;17(2):70-6. doi: 10.1007/BF01646879. Infection. 1989. PMID: 2714860

7

Phylogenetic and case-control study on hepatitis E virus infection in Germany.

Wichmann O, Schimanski S, Koch J, Kohler M, Rothe C, Plentz A, Jilg W, Stark K. Wichmann O, et al. Among authors: jilg w. J Infect Dis. 2008 Dec 15;198(12):1732-41. doi: 10.1086/593211. J Infect Dis. 2008. PMID: 18983248

8

Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults.

Knöll A, Hottenträger B, Kainz J, Bretschneider B, Jilg W. Knöll A, et al. Among authors: jilg w. Vaccine. 2000 Apr 3;18(19):2029-32. doi: 10.1016/s0264-410x(99)00524-1. Vaccine. 2000. PMID: 10706965 Clinical Trial.

9

Determinants of Long-term protection after hepatitis B vaccination in infancy: a meta-analysis.

Schönberger K, Riedel C, Rückinger S, Mansmann U, Jilg W, Kries RV. Schönberger K, et al. Among authors: jilg w. Pediatr Infect Dis J. 2013 Apr;32(4):307-13. doi: 10.1097/INF.0b013e31827bd1b0. Pediatr Infect Dis J. 2013. PMID: 23249904 Review.

10

Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine.

Maiwald H, Jilg W, Bock HL, Löscher T, Sonnenburg F. Maiwald H, et al. Among authors: jilg w. Vaccine. 1997 Mar;15(4):346-8. doi: 10.1016/s0264-410x(97)00211-9. Vaccine. 1997. PMID: 9141202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters